AYTU BIOPHARMA, INC Quarterly Preferred Stock, Shares Authorized from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Aytu Biopharma, Inc quarterly Preferred Stock, Shares Authorized history and growth rate from Q3 2011 to Q2 2024.
  • Aytu Biopharma, Inc Preferred Stock, Shares Authorized for the quarter ending June 30, 2024 was 50M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 50M 0 0% Jun 30, 2024 10-K 2024-09-26
Q1 2024 50M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 50M 0 0% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 50M 0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 50M 0 0% Jun 30, 2023 10-K 2024-09-26
Q1 2023 50M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 50M 0 0% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 50M 0 0% Sep 30, 2022 10-Q/A 2023-02-21
Q2 2022 50M 0 0% Jun 30, 2022 10-K 2023-10-12
Q1 2022 50M 0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 50M 0 0% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 50M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 50M 0 0% Jun 30, 2021 10-K 2022-09-27
Q1 2021 50M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 50M 0 0% Dec 31, 2020 10-Q 2021-05-17
Q3 2020 50M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 50M 0 0% Jun 30, 2020 10-K 2021-09-28
Q1 2020 50M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 50M 0 0% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 50M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 50M 0 0% Jun 30, 2019 10-K 2020-10-06
Q1 2019 50M 0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 50M 0 0% Dec 31, 2018 10-Q/A 2019-05-14
Q3 2018 50M 0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 50M 0 0% Jun 30, 2018 10-K 2019-09-26
Q1 2018 50M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 50M 0 0% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 50M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 50M 0 0% Jun 30, 2017 10-K 2018-09-06
Q1 2017 50M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 50M 0 0% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 50M 0 0% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 50M 0 0% Jun 30, 2016 10-K 2017-08-31
Q1 2016 50M +30M +150% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 50M +45M +900% Dec 31, 2015 10-Q 2016-02-11
Q3 2015 50M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 50M 0 0% Jun 30, 2015 10-K 2016-09-01
Q1 2015 20M +15M +300% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 5M 0 0% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 50M +45M +900% Sep 30, 2014 10-Q 2015-11-06
Q2 2014 50M +45M +900% Jun 30, 2014 10-K 2015-09-30
Q1 2014 5M 0 0% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 5M 0 0% Nov 30, 2013 10-Q 2014-01-10
Q3 2013 5M 0 0% Aug 31, 2013 10-K 2014-11-26
Q2 2013 5M 0 0% May 31, 2013 10-Q 2013-06-28
Q1 2013 5M 0 0% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 5M 0 0% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 5M 0 0% Aug 31, 2012 10-K 2014-11-26
Q2 2012 5M May 31, 2012 10-Q 2012-06-26
Q1 2012 5M Feb 29, 2012 10-Q 2012-04-12
Q4 2011 5M Nov 30, 2011 10-Q 2011-12-23
Q3 2011 5M Aug 31, 2011 10-K 2012-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.